Clinical Trial Update: Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 single-dose pharmacodynamic study comparing torasemide extended-release 10 mg, torasemide immediate-release 10 mg, and furosemide immediate-release 40 m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Furosemide-IR 40 mg (furosemide)
• Torasemide-IR 10 mg (torasemide)
• Torasemide-PR 10 mg (torasemide)

Snippet

Sponsor: Ferrer Internacional S.A. | Conditions: Compensated Heart Failure | Phase 4 | Status: TERMINATED